论文部分内容阅读
作者对种种治疗无效的重症型小儿哮喘10例(男5,女5)给予口服经皮接种的BCG疫苗,取得满意效果。观察的10例皆为小儿科门诊或住院病人,年龄8～17岁,支气管哮喘初发年龄平均2.9岁,平均病程7.4年。其中,过敏型9例,混合型1例。其方法,将80mg的BCG溶于100ml水中,早晨空腹服下,若以后仍残留有气喘或咳嗽等病症,于一周后第二次服用,全疗程最多服用4次。治疗中黄嘌呤类药,抗过敏、抗组织胺药等一般治疗继续进行。治疗后哮喘全部症状消失者为显效;有减轻而仍残留部分者为有效;无改变或加重者属无效。
The authors of 10 kinds of severe asthma treatment ineffective (male 5, female 5) given oral transdermal BCG vaccine, and achieved satisfactory results. 10 cases were observed pediatric outpatient or inpatient, aged 8 to 17 years old, the average age of onset of bronchial asthma 2.9 years, the average duration of 7.4 years. Among them, 9 cases were allergic and 1 case was mixed. The method, 80mg of BCG dissolved in 100ml of water, morning fasting dose, if there is still residual asthma or cough and other illnesses, the second time a week after taking the whole course of taking up to 4 times. The treatment of xanthines, anti-allergy, antihistamines and other general treatment continue. After treatment, all the symptoms of asthma disappeared were markedly effective; there are still some of the remaining part of the reduction is effective; no change or increase is ineffective.